Search results
Results from the WOW.Com Content Network
"Nice to Meet You" is a song by British singer-songwriter Myles Smith. It was released on 8 November 2024 as the fourth single from his second extended play A Minute.... [1] Upon release, Smith said: "It's inspired by stories from friends in my life. A reminder that the right person can change everything, often when you least expect it." [2]
The first study involved 382 participants also taking the maximum tolerated doses of statins. [2] After three months, LDL cholesterol levels were reduced by 36% in participants taking bempedoic acid and ezetimibe compared with a reduction of 23% with ezetimibe alone, 17% with bempedoic acid alone and an increase of around 2% with placebo (a ...
The effects of rosuvastatin on low-density lipoprotein (LDL) cholesterol are dose-related. Higher doses were more efficacious in improving the lipid profile of patients with hypercholesterolemia than milligram-equivalent doses of atorvastatin and milligram-equivalent or higher doses of simvastatin and pravastatin. [11]
They recommended selective use of low-to-moderate doses statins in the same adults who have a calculated 10-year cardiovascular disease event risk of 7.5–10% or greater. [22] In people over the age of 70, statins decrease the risk of cardiovascular disease but only in those with a history of heavy cholesterol blockage in their arteries. [24]
Smith was born to a British Jamaican family in Luton on 3 June 1998 [1] [2] and raised in an ethnically diverse community. He grew up listening to a broad range of music, including pop-punk, singer/songwriters, and hip-hop.
"Nice to Meet You" (Forever the Sickest Kids song), 2013 "Nice to Meet You" (Imagine Dragons song), 2024 "Nice to Meet You" (Myles Smith song), 2024 "Nice to Meet You" (PinkPantheress song), 2023
In two RCTs an average dose of 72 mg/day fluvastatin reduced LDL cholesterol by 31.9%, and reduced myocardial infarction, relative risk, 0.68 (95% CI 0.55 to 0.85) as compared to placebo. In five RCTs a mean atorvastatin dose of 26 mg/day reduced LDL cholesterol by 44.0% and reduced myocardial infarction, relative risk, 0.67 (95% CI 0.58 to 0. ...
However, due to its relatively severe adverse effects in comparison to other statins, its market use was discontinued. [citation needed] The strengths of the available cerivastatin medicine ranged from 0.2 - 0.8 mg, resulting in an actual dose of 1.9 - 13.1 μg/kg body weight for which rhabdomyolysis has been reported. [14]